These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36941368)

  • 1. A mathematical model and numerical simulation for SARS-CoV-2 dynamics.
    Amoddeo A
    Sci Rep; 2023 Mar; 13(1):4575. PubMed ID: 36941368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
    Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells.
    Bernhauerová V; Lisowski B; Rezelj VV; Vignuzzi M
    J Theor Biol; 2021 Dec; 531():110895. PubMed ID: 34499915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the double trouble: A mathematical modelling of co-infection dynamics of SARS-CoV-2 and influenza-like illness.
    Bhowmick S; Sokolov IM; Lentz HHK
    Biosystems; 2023 Feb; 224():104827. PubMed ID: 36626949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiscale multicellular spatiotemporal model of local influenza infection and immune response.
    Sego TJ; Mochan ED; Ermentrout GB; Glazier JA
    J Theor Biol; 2022 Jan; 532():110918. PubMed ID: 34592264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational simulations to dissect the cell immune response dynamics for severe and critical cases of SARS-CoV-2 infection.
    Blanco-Rodríguez R; Du X; Hernández-Vargas E
    Comput Methods Programs Biomed; 2021 Nov; 211():106412. PubMed ID: 34610492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary innate immune response in Sars-cov-2 infection].
    Bottino E; Ponce AA
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Mar; 79(1):33-42. PubMed ID: 35312259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
    Elaiw AM; Alsulami RS; Hobiny AD
    Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
    Melissa Hallow K; Dave I
    Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.